To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in the life sciences sector, BioSpectrum Asia organised the Excellence Awards 2024 in Singapore on 6th December.

This prestigious event honoured the outstanding performers of the calendar year 2023 & 2024, underscoring Asia’s emergence as a global hub for innovation and growth in the life sciences industry.

The BioSpectrum Asia Excellence Awards 2024 comprised of two segments- Jury Special and Industry Special Awards. 

Winners for our Industry Special segment included-

Top Company for Bioprocessing - Eppendorf

Top Company in Manufacturing Technology & Equipment - Cytiva

Top Company in Packaging & Drug Delivery Services - West Pharma

Top Company in Supply Chain Logistics & Distribution – Catalent Pharma Solutions

Top Company in Clinical Research-Based Development - Medidata

Top Innovation & Collaborations in ADC Drug Development – GenScript Biotech

Innovative Biotech Solutions - Ardor Biomed India

Emerging Al Powered Drug Discovery Platform - Molecule AI

Top Company in Medical Packaging - Oliver Healthcare Packaging

Outstanding Leadership in MedTech Advocacy in Asia-Pacific Award- Special Recognition – APACMed

Excellence in medtech innovation- Medtronic

Winners of the Jury Special category included-

Entrepreneur of the year- Dr Jogin Desai from Eyestem Research & Dr Lynne Lim for NousQ

Emerging startup of the year- ImmunoAct, and Aevice Health

Businessperson of the year- Dr Christian Behrenbruch, Managing Director and Group CEO of Telix Pharmaceuticals

Product of the year- Needle free injection system technology by IntegriMedical

In conjunction with the prestigious BioSpectrum Asia Excellence Awards 2024, a panel discussion was organised on the critical topic: "Biomanufacturing: Advancing Towards a Sustainable Bioeconomy in Asia." powered by Cytiva.

The discussion was moderated by Dr Satya Dash- President Strategy Bigtec, Founding Head Strategy, BIRAC, Government of India; while the speakers included Damian Cher, Director of Manufacturing Capacity Solution in Asia Pacific, Cytiva; Franco So, Head of Bioprocess, Sales, Asia Pacific China, Eppendorf; Lew Fei-Chuin, Biopharma Market Manager, Agilent Technologies; Dr. Saket Jhajharia, Chief Operating Officer, ID Capital; and Dr Dario Heymann, Chief Research Officer, Galen Growth Singapore & AI Office, SingHealth.

BioSpectrum Asia is proud to play a critical role of picking tomorrow's winners, nudging today's entrepreneurs to achieve greater glory and honouring yesterday's key players who laid the foundation for success.

To access the event gallery, please click here-

BioSpectrum Asia Excellence Awards 2024

About BioSpectrum Asia Awards-

Back in 2006, the Asia edition of BioSpectrum was launched to chronicle the growth of the Life Sciences sector in the Asia region. Since its launch in March 2006 in Singapore, the magazine has been successful in bringing an Asian flavour to the world of life sciences, dominated for over a century by global companies.

BioSpectrum Asia’s inaugural Life Sciences Industry Award was conceptualised in 2008 and the event took place in 2009. After organising several successful annual events to celebrate and recognise leadership, entrepreneurship and innovation in Asia’s life sciences industry since 2009, and with a small gap in between, we are now back to continue this legacy forward in 2022.